학술논문

Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium
Document Type
article
Source
The Journal of Infectious Diseases. 222(Supplement_3)
Subject
Microbiology
Biological Sciences
Biomedical and Clinical Sciences
Emerging Infectious Diseases
Clinical Research
Vaccine Related
Infection
Quality Education
Antifungal Agents
Antimicrobial Stewardship
Clinical Competence
Drug Monitoring
Drug Prescriptions
Drug Resistance
Fungal
Evidence-Based Medicine
Humans
Inappropriate Prescribing
Mycoses
Practice Guidelines as Topic
stewardship
antifungal
candidiasis
aspergillosis
guidelines
diagnostics
Medical and Health Sciences
Biological sciences
Biomedical and clinical sciences
Health sciences
Language
Abstract
In recent years, the global public health community has increasingly recognized the importance of antimicrobial stewardship (AMS) in the fight to improve outcomes, decrease costs, and curb increases in antimicrobial resistance around the world. However, the subject of antifungal stewardship (AFS) has received less attention. While the principles of AMS guidelines likely apply to stewarding of antifungal agents, there are additional considerations unique to AFS and the complex field of fungal infections that require specific recommendations. In this article, we review the literature on AMS best practices and discuss AFS through the lens of the global core elements of AMS. We offer recommendations for best practices in AFS based on a synthesis of this evidence by an interdisciplinary expert panel of members of the Mycoses Study Group Education and Research Consortium. We also discuss research directions in this rapidly evolving field. AFS is an emerging and important component of AMS, yet requires special considerations in certain areas such as expertise, education, interventions to optimize utilization, therapeutic drug monitoring, and data analysis and reporting.